Background Even though the lives of millions have been saved in the past decades, the
mortality rate in patients with drug-resistant tuberculosis is still high. Different factors are …

Little is known about the impact of comorbidities on multidrug resistant (MDR) and
extensively drug resistant (XDR) tuberculosis (TB) treatment outcomes. We aimed to …

Abstract The bacterium Mycobacterium tuberculosis (Mtb) causes tuberculosis and is
responsible for more human mortality than any other single pathogen. Progression to active …

Background. Resistance to second-line drugs develops during treatment of multidrug-
resistant (MDR) tuberculosis, but the impact on treatment outcome has not been determined …

Molecular diagnostics that rapidly and accurately predict resistance to fluoroquinolone drugs
and especially later-generation agents promise to improve treatment outcomes for patients …

Background Comorbid conditions and adverse drug events are associated with poor
treatment outcomes among patients with drug resistant tuberculosis (DR–TB). This study …

Objective To assess poor treatment outcomes and their predictors among drug-resistant
tuberculosis patients treated in Ethiopia. Methods Data were searched from both electronic …

Background Ukraine is among ten countries with the highest burden of multidrug-resistant
TB (MDR-TB) worldwide. Treatment success rates for MDR-TB in Ukraine remain below …

SETTINGS: Although Pakistan has a high burden of multidrug-resistant tuberculosis (MDR-
TB), little is known about the management and treatment outcomes of MDR-TB patients in …

Objectives We aimed to determine the characteristics, treatment outcomes and risk factors
for poor treatment outcomes among multidrug-resistant (MDR) tuberculosis (TB) patients in …